References
- BrockGHsuGLNunesLvon HeydenBLueTFThe anatomy of the tunica albuginea in the normal penis and Peyronie’s diseaseJ Urol19971572762818976279
- DevineCJSomersKDJordanSGSchlossbergSMProposal: trauma as the cause of the Peyronie’s lesionJ Urol19971571285290 Available from: http://www.ncbi.nlm.nih.gov/pubmed/8976281Accessed March 8, 20158976281
- TaylorFLLevineLAPeyronie’s diseaseUrol Clin North Am20073451753417983892
- SchwarzerUSommerFKlotzTBraunMReifenrathBEngelmannUThe prevalence of Peyronie’s disease: results of a large surveyBJU Int20018872773011890244
- LindsayMBSchainDMGrambschPBensonRCBeardCMKurlandLTThe incidence of Peyronie’s disease in Rochester, Minnesota, 1950 through 1984J Urol1991146410071009 Available from: http://www.ncbi.nlm.nih.gov/pubmed/1895413Accessed March 9, 20151895413
- DibenedettiDBNguyenDZografosLZiemieckiRZhouXA population-based study of Peyronie’s disease: prevalence and treatment patterns in the United StatesAdv Urol201120111013
- ShiraishiKShimabukuroTMatsuyamaHThe prevalence of Peyronie’s disease in Japan: a study in men undergoing maintenance hemodialysis and routine health checksJ Sex Med201292716272322897619
- La PeraGPescatoriESCalabreseMSIMONA Study GroupPeyronie’s disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50–69 yearsEur Urol2001405525530 Available from: http://www.ncbi.nlm.nih.gov/pubmed/11752860Accessed March 10, 201511752860
- MulhallJPCreechSDBoorjianSASubjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screeningJ Urol20041716 pt 123502353 Available from: http://www.ncbi.nlm.nih.gov/pubmed/15126819Accessed March 7, 201515126819
- GholamiSSGonzalez-CadavidNFLinC-SRajferJLueTFPeyronie’s disease: a reviewJ Urol2003169April1234124112629334
- BjekicMDVlajinacHDSipeticSBMarinkovicJMRisk factors for Peyronie’s disease: a case-control studyBJU Int20069757057416469028
- KendirciMTrostLSikkaSCHellstromWJGDiabetes mellitus is associated with severe Peyronie’s diseaseBJU Int20079938338617313425
- RhodenELRiednerCEFuchsSCFuchsSRibeiroEPHalmenschlagerGA cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie’s diseaseJ Sex Med201074 pt 11529153719912489
- NugterenHMNijmanJMde JongIJvan DrielMFThe association between Peyronie’s and Dupuytren’s diseaseInt J Impot Res201123414214521633367
- CarrieriMPSerrainoDPalmiottoFNucciGSassoFA case-control study on risk factors for Peyronie’s diseaseJ Clin Epidemiol1998516511515 Available from: http://www.ncbi.nlm.nih.gov/pubmed/9636000Accessed June 2, 20159636000
- NelsonCJDiblasioCKendirciMHellstromWGuhringPMulhallJPThe chronology of depression and distress in men with Peyronie’s diseaseJ Sex Med2008581985199018554257
- SmithJFWalshTJContiSLTurekPLueTRisk factors for emotional and relationship problems in Peyronie’s diseaseJ Sex Med2008592179218418638001
- HellstromWJGFeldmanRRosenRCSmithTKaufmanGTursiJBother and distress associated with Peyronie’s disease: validation of the Peyronie’s disease questionnaireJ Urol2013190262763423376705
- MulhallJPSchiffJGuhringPAn analysis of the natural history of Peyronie’s diseaseJ Urol200617521152118 discussion 211816697815
- ChungEDe YoungLBrockGBPenile duplex ultrasonography in men with Peyronie’s disease: is it veno-occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?J Sex Med20118123446345121981553
- El-SakkaAIHassobaHMPillarisettyRJDahiyaRLueTFPeyronie’s disease is associated with an increase in transforming growth factor-beta protein expressionJ Urol19971584139113949302128
- BrantWODeanRCLueTFTreatment of Peyronie’s disease with oral pentoxifyllineNat Clin Pract Urol200632111115 quiz 11616470210
- SafarinejadMRAsgariMAHosseiniSYDadkhahFA double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie’s diseaseBJU Int201010624024819863517
- SmithJFShindelAWHuangY-CPentoxifylline treatment and penile calcifications in men with Peyronie’s diseaseAsian J Androl201113232232521102473
- NehraAAlterowitzRCulkinDJAmerican Urological Association Education and Research IncPeyronie’s disease: AUA guidelineJ Urol2015194374575326066402
- SafarinejadMRHosseiniSYKolahiAAComparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie’s disease: a double-blind, placebo controlled, randomized studyJ Urol200717841398140317706714
- InalTTokatliZAkandMOzdilerEYamanOEffect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie’s disease: a randomized and prospective studyUrology20066751038104210.1016/j.urology.2005.11.00516581113
- Prieto CastroRMLeva VallejoMERegueiro LopezJCAnglada CuradoFJAlvarez KindelanJRequena TapiaMJCombined treatment with vitamin E and colchicine in the early stages of Peyronie’s diseaseBJU Int200391652252412656907
- WeidnerWHauckEWSchnitkerJPotassium paraaminobenzoate (POTABA™) in the treatment of Peyronie’s disease: a prospective, placebo-controlled, randomized studyEur Urol200547453053515774254
- AkkusECarrierSRehmanJBrezaJKadiogluALueTFIs colchicine effective in Peyronie’s disease? A pilot studyUrology1994442291295 Available from: http://www.ncbi.nlm.nih.gov/pubmed/8048212Accessed June 16, 20158048212
- SafarinejadMRTherapeutic effects of colchicine in the management of Peyronie’s disease: a randomized double-blind, placebo-controlled studyInt J Impot Res200416323824314973528
- TelokenCRhodenELGrazziotinTMRosCTSogariPRSoutoCATamoxifen versus placebo in the treatment of Peyronie’s diseaseJ Urol1999162620032005 Available from: ttp://www.ncbi.nlm.nih.gov/pubmed/10569556Accessed June 16, 201510569556
- BiagiottiGCavalliniGAcetyl- L-carnitine vs tamoxifen in the oral therapy of Peyronie’s disease: a preliminary reportBJU Int200188636711446848
- RussellSSteersWMcVaryKTSystematic evidence-based analysis of plaque injection therapy for Peyronie’s diseaseEur Urol200751364064717092631
- SafarinejadMRSafety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie’s disease: a double-blind, placebo-controlled randomized studyInt J Impot Res201022529830920720560
- LacyGLAdamsDMHellstromWJGIntralesional interferon-alpha-2b for the treatment of Peyronie’s diseaseInt J Impot Res200214533633912454683
- HellstromWJGKendirciMMaternRSingle-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie’s diseaseJ Urol2006176139439816753449
- TrostLWAtesEPowersMSikkaSHellstromWJGOutcomes of intralesional interferon-a2B for the treatment of Peyronie diseaseJ Urol201319062194219923688848
- FavillaVRussoGIPriviteraSCombination of intralesional verapamil and oral antioxidants for Peyronie’s disease: a prospective, randomised controlled studyAndrologia201346893694224124921
- RothMEickelbergOKohlerEErnePBlockLHCa2+ channel blockers modulate metabolism of collagens within the extracellular matrixProc Natl Acad Sci U S A1996931154785482 Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=39271&tool=pmcentrez&rendertype=abstractAccessed June 16, 20158643600
- MulhallJPCreechSDBoorjianSASubjective and objective analysis of the prevalence of Peyronie’s disease in a population of men presenting for prostate cancer screeningJ Urol200410.1097/01.ju.0000127744.18878.f1
- PendletonCWangRPeyronie’s disease: current therapyTransl Androl Urol201323152326816719
- RehmanJBenetAMelmanAUse of intralesional verapamil to dissolve Peyronie’s disease plaque: a long-term single-blind studyUrology19985146206269586617
- GelbardMGoldsteinIHellstromWJGClinical efficacy, safety and tolerability of collagenase Clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studiesJ Urol2013190119920723376148
- LevineLACuzinBMarkSClinical safety and effectiveness of collagenase Clostridium histolyticum injection in patients with Peyronie’s disease: a phase 3 open-label studyJ Sex Med201512124825825388099
- LevineLANewellMTaylorFLPenile traction therapy for treatment of Peyronie’s disease: a single-center pilot studyJ Sex Med2008561468147318373527
- YafiFAPinskyMRStewartCThe Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie’s DiseaseJ Urol2015615
- RaheemAAGaraffaGRaheemTAThe role of vacuum pump therapy to mechanically straighten the penis in Peyronie’s diseaseBJU Int201010681178118020438558
- GreenfieldJMShahSJLevineLAVerapamil versus saline in electromotive drug administration for Peyronie’s disease: a double-blind, placebo controlled trialJ Urol2007177397297517296390
- HauckEWMuellerUOBschleipferTSchmelzHUDiemerTWeidnerWExtracorporeal shock wave therapy for Peyronie’s disease: exploratory meta-analysis of clinical trialsJ Urol20041712 pt 174074514713800
- PalmieriAImbimboCLongoNA first prospective, randomized, double-blind, placebo-controlled clinical trial evaluating extracorporeal shock wave therapy for the treatment of Peyronie’s diseaseEur Urol200956236337019473751
- RalphDGonzalez-CadavidNMironeVThe management of Peyronie’s disease: EVIDENCE-based 2010 guidelinesJ Sex Med2010772359237420497306
- LevineLALarsenSMSurgery for Peyronie’s diseaseAsian J Androl2012151273423178395
- OhebshalomMMulhallJGuhringPParkerMMeasurement of penile curvature in Peyronie’s disease patients: comparison of three methodsJ Sex Med20074119920317233785
- AndrewsHOAl-AkraaMPryorJPRalphDJThe Nesbit operation for congenital curvature of the penisInt J Impot Res1999113119122 Available from: http://www.ncbi.nlm.nih.gov/pubmed/10404279Accessed June 16, 201510404279
- YachiaDModified corporoplasty for the treatment of penile curvatureJ Urol199014318082 Available from: http://www.ncbi.nlm.nih.gov/pubmed/2294269Accessed June 16, 20152294269
- GholamiSSLueTFCorrection of penile curvature using the 16-dot plication technique: a review of 132 patientsJ Urol200216752066206911956440
- BrantWOBellaAJLueTF16-Dot procedure for penile curvatureJ Sex Med20074227728017367422
- GreenfieldJMLucasSLevineLAFactors affecting the loss of length associated with tunica albuginea plication for correction of penile curvatureJ Urol2006175123824116406919
- TaylorFLLevineLASurgical correction of Peyronie’s disease via tunica albuginea plication or partial plaque excision with pericardial graft: long-term follow upJ Sex Med2008592221222818637996
- TornehlCKCarsonCCSurgical alternatives for treating Peyronie’s diseaseBJU Int200494677478315476507
- TaylorFLAbernMRLevineLAPredicting erectile dysfunction following surgical correction of Peyronie’s disease without inflatable penile prosthesis placement: vascular assessment and preoperative risk factorsJ Sex Med20129129630121951516
- CormioLZucchiALorussoFSurgical treatment of Peyronie’s disease by plaque incision and grafting with buccal mucosaEur Urol20095561469147619084325
- GelbardMKRelaxing incisions in the correction of penile deformity due to Peyronie’s diseaseJ Urol1995154414571460 Available from: http://www.ncbi.nlm.nih.gov/pubmed/7658558Accessed June 16, 20157658558
- KadiogluASanliOAkmanTErsayAGuvenSMammadovFGraft materials in Peyronie’s disease surgery: a comprehensive reviewJ Sex Med20074358159517419820
- TelokenCGrazziotinTRhodenEPenile straightening with crural graft of the corpus cavernosumJ Urol2000164110710810840434
- KnollLDUse of small intestinal submucosa graft for the surgical management of Peyronie’s diseaseJ Urol2007178624742478 discussion 247817976656
- ChunJLMcGregorAKrishnanRCarsonCCA comparison of dermal and cadaveric pericardial grafts in the modified Horton-Devine procedure for Peyronie’s diseaseJ Urol2001166118518811435853
- JohnTBandiGSantucciRPorcine small intestinal submucosa is not an ideal graft material for Peyronie’s disease surgeryJ Urol200617631025102916890683
- HatzichristodoulouGGschwendJELahmeSSurgical therapy of Peyronie’s disease by partial plaque excision and grafting with collagen fleece: feasibility study of a new techniqueInt J Impot Res201325518318723446807
- UstaMFBivalacquaTJSanabriaJKoksalITMopartyKHellstromWJGPatient and partner satisfaction and long-term results after surgical treatment for Peyronie’s diseaseUrology200362110510912837432
- KovacJRBrockGBSurgical outcomes and patient satisfaction after dermal, pericardial, and small intestinal submucosal grafting for Peyronie’s diseaseJ Sex Med2007451500150817433088
- LeungwattanakijSBivalacquaTJReddySHellstromWJLong-term follow-up on use of pericardial graft in the surgical management of Peyronie’s diseaseInt J Impot Res2001133183186 Available from: http://www.ncbi.nlm.nih.gov/pubmed/11525318Accessed June 16, 201511525318
- LevineLAEstradaCRHuman cadaveric pericardial graft for the surgical correction of Peyronie’s diseaseJ Urol20031706 pt 12359236214634416
- BreyerBNBrantWOGarciaMMBellaAJLueTFComplications of porcine small intestine submucosa graft for Peyronie’s diseaseJ Urol2007177258959117222639
- StaermanFPierrevelcinJRipertTMenardJMedium-term follow-up of plaque incision and porcine small intestinal submucosal grafting for Peyronie’s diseaseInt J Impot Res201022634334821124338
- LeeEWShindelAWBrandesSBSmall intestinal submucosa for patch grafting after plaque incision in the treatment of Peyronie’s diseaseInt Braz J Urol2008342191196 discussion 197. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18462517Accessed June 16, 201518462517
- PeritoPWilsonSThe Peyronie’s plaque “scratch”: an adjunct to modelingJ Sex Med201310511941197 Available from: http://www.ncbi.nlm.nih.gov/pubmed/23750353Accessed December 21, 201523750353
- RolleLCerutiCTimpanoMA new, innovative, lengthening surgical procedure for Peyronie’s disease by penile prosthesis implantation with double dorsal-ventral patch graft: the “sliding technique”J Sex Med2012992389239522429331
- SansaloneSGaraffaGDjinovicRSimultaneous penile lengthening and penile prosthesis implantation in patients with Peyronie’s disease, refractory erectile dysfunction, and severe penile shorteningJ Sex Med20129131632122023552